Currently out of the existing stock ratings of William Pickering, 28 are a HOLD (43.08%), 32 are a BUY (49.23%), 5 are a SELL (7.69%).

William Pickering

Work Performance Price Targets & Ratings Chart

Analyst William Pickering, currently employed at BERNSTEIN, carries an average stock price target met ratio of 75.14% that have a potential upside of 24.76% achieved within 144 days.

William Pickering’s has documented 124 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical at 05-May-2026.

Wall Street Analyst William Pickering

Analyst best performing recommendations are on CRSP (CRISPR THERAPEUTICS AG).
The best stock recommendation documented was for ALNY (ALNYLAM PHARMACEUTICALS) at 7/30/2025. The price target of $389 was fulfilled within 1 day with a profit of $49.2 (14.48%) receiving and performance score of 144.79.

Average potential price target upside

of $187.67 (30.14%) on REGN (REGENERON PHARMACEUTICALS).
of $45.58 (19.56%) on ALNY (ALNYLAM PHARMACEUTICALS).
of $29.18 (8.09%) on VRTX (VERTEX PHARMACEUTICALS).

ALLO Allogene Therapeutics ALNY Alnylam Pharmaceuticals ARWR Arrowhead Pharmaceuticals BEAM Beam Therapeutics BHVN Biohaven Pharmaceutical Holding Co Ltd BIIB Biogen BMRN Biomarin Pharmaceutical CRSP Crispr Therapeutics AG DYN Dyne Therapeutics IONS Ionis Pharmaceuticals NTLA Intellia Therapeutics REGN Regeneron Pharmaceuticals SRPT Sarepta Therapeutics VRTX Vertex Pharmaceuticals

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Robert Burns (HC WAINWRIGHT)